Figure 1From: Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study Representative SELDI-TOF MS spectra showing the intensity of the peaks with an m/z of 4276, 4292, 8129 and 8941 in breast cancer cases and healthy controls.Back to article page